ODAC Calls For Tougher Standards For Accelerated Approval In Oncology
Sponsors Withdraw Indications for Iressa, Celebrex
Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals
White House Yet To Name NCAB, Cancer Panel Members
NCI Largely Unaffected By NIH Translational Research Center
Trending Stories
- Lei Zheng named executive director of Mays Cancer Center
- Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence - In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”